- Home
- CPIX vs SST Comparison
CPIX vs SST Comparison
Compare CPIX & SST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- SST
- Stock Information
- Founded
- CPIX 1999
- SST 2013
- Country
- CPIX United States
- SST United States
- Employees
- CPIX N/A
- SST N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- SST Diversified Commercial Services
- Sector
- CPIX Health Care
- SST Consumer Discretionary
- Exchange
- CPIX Nasdaq
- SST Nasdaq
- Market Cap
- CPIX 48.5M
- SST 57.3M
- IPO Year
- CPIX 2009
- SST N/A
- Fundamental
- Price
- CPIX $3.23
- SST $8.36
- Analyst Decision
- CPIX
- SST Strong Buy
- Analyst Count
- CPIX 0
- SST 1
- Target Price
- CPIX N/A
- SST $10.00
- AVG Volume (30 Days)
- CPIX 32.7K
- SST 49.0K
- Earning Date
- CPIX 11-06-2025
- SST 11-06-2025
- Dividend Yield
- CPIX N/A
- SST N/A
- EPS Growth
- CPIX N/A
- SST N/A
- EPS
- CPIX N/A
- SST N/A
- Revenue
- CPIX $42,071,813.00
- SST $317,055,000.00
- Revenue This Year
- CPIX N/A
- SST N/A
- Revenue Next Year
- CPIX N/A
- SST $12.20
- P/E Ratio
- CPIX N/A
- SST N/A
- Revenue Growth
- CPIX 11.34
- SST N/A
- 52 Week Low
- CPIX $1.04
- SST $2.90
- 52 Week High
- CPIX $7.25
- SST $15.00
- Technical
- Relative Strength Index (RSI)
- CPIX 43.51
- SST 60.63
- Support Level
- CPIX $3.26
- SST $7.51
- Resistance Level
- CPIX $3.57
- SST $9.00
- Average True Range (ATR)
- CPIX 0.20
- SST 0.59
- MACD
- CPIX -0.01
- SST 0.08
- Stochastic Oscillator
- CPIX 4.17
- SST 73.11
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.